Ignite Creation Date:
2025-12-24 @ 9:07 PM
Ignite Modification Date:
2026-02-18 @ 2:55 AM
Study NCT ID:
NCT04139304
Status:
RECRUITING
Last Update Posted:
2025-06-29
First Post:
2019-10-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma
Sponsor:
AIDS Malignancy Consortium
Organization:
Organization Data
Organization:
Class:
NETWORK
Study ID:
AMC-105
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NETWORK
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None